The incorporation of faecal calprotectin testing in the assessment of IBD activity can half the cost of disease reassessment in a specialist IBD clinic, according to an Australian study. The findings provide more compelling support for efforts to secure an MBS item number for the test. The Victorian study compared patients treated at a clinic between ...
Faecal calprotectin reduces cost but not quality of IBD care
By Mardi Chapman
4 Jul 2018